STOCK TITAN

[8-K] bioAffinity Technologies, Inc. Warrant Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Savers Value Village, Inc. (SVV) filed a Form 144 indicating that an insider intends to sell up to 600 common shares through Fidelity Brokerage Services on or after 22 Jul 2025. Based on the reference price in the notice, the stake is valued at $6,306. With 157,451,564 shares outstanding, the proposed sale equals roughly 0.0004 % of the float, implying negligible market impact.

The seller, identified in the three-month sales table as Richard Medway, has already disposed of 36,513 shares between May and July 2025 for gross proceeds of about $402 k. The 600 shares originate from a stock option granted 12 Jun 2019 and exercised for cash on the planned sale date.

This filing is routine compliance with Rule 144 for restricted/control securities. Given the de-minimis size relative to daily volume and market cap, the event is unlikely to influence valuation, though investors may note the ongoing insider selling trend.

Savers Value Village, Inc. (SVV) ha presentato un Modulo 144 indicando che un insider intende vendere fino a 600 azioni ordinarie tramite Fidelity Brokerage Services a partire dal 22 luglio 2025. In base al prezzo di riferimento indicato nella comunicazione, la quota è valutata circa 6.306 $. Con 157.451.564 azioni in circolazione, la vendita proposta rappresenta circa lo 0,0004% del flottante, con un impatto di mercato trascurabile.

Il venditore, identificato nella tabella delle vendite trimestrali come Richard Medway, ha già ceduto 36.513 azioni tra maggio e luglio 2025 per un ricavo lordo di circa 402.000 $. Le 600 azioni provengono da un'opzione su azioni concessa il 12 giugno 2019 e esercitata in contanti nella data prevista per la vendita.

Questa comunicazione è una conformità di routine alla Regola 144 per titoli con restrizioni o di controllo. Considerata la dimensione minima rispetto al volume giornaliero e alla capitalizzazione di mercato, l'evento difficilmente influenzerà la valutazione, anche se gli investitori potrebbero osservare la tendenza continua delle vendite da parte degli insider.

Savers Value Village, Inc. (SVV) presentó un Formulario 144 indicando que un insider planea vender hasta 600 acciones comunes a través de Fidelity Brokerage Services a partir del 22 de julio de 2025. Según el precio de referencia en el aviso, la participación está valorada en 6,306 $. Con 157,451,564 acciones en circulación, la venta propuesta equivale aproximadamente al 0,0004% del flotante, lo que implica un impacto de mercado insignificante.

El vendedor, identificado en la tabla de ventas trimestrales como Richard Medway, ya ha vendido 36,513 acciones entre mayo y julio de 2025, obteniendo ingresos brutos de aproximadamente 402,000 $. Las 600 acciones provienen de una opción de compra otorgada el 12 de junio de 2019 y ejercida en efectivo en la fecha prevista para la venta.

Esta presentación es un cumplimiento rutinario con la Regla 144 para valores restringidos o de control. Dado el tamaño mínimo en relación con el volumen diario y la capitalización de mercado, es poco probable que el evento influya en la valoración, aunque los inversores pueden notar la tendencia continua de ventas por parte de insiders.

Savers Value Village, Inc. (SVV)는 내부자가 2025년 7월 22일 이후 Fidelity Brokerage Services를 통해 최대 600주의 보통주를 매도할 계획임을 알리는 Form 144를 제출했습니다. 공지에 명시된 기준 가격에 따르면 해당 지분 가치는 6,306달러로 평가됩니다. 총 157,451,564주가 발행된 가운데, 이번 매도는 유통 주식의 약 0.0004%에 해당하여 시장에 미치는 영향은 미미할 것으로 보입니다.

판매자는 3개월 매도 내역표에서 리처드 메드웨이(Richard Medway)로 확인되며, 2025년 5월부터 7월 사이에 이미 36,513주를 매도하여 약 40만 2천 달러의 총수익을 올렸습니다. 이번 600주는 2019년 6월 12일에 부여된 주식 옵션에서 기인하며, 계획된 매도일에 현금으로 행사되었습니다.

이번 제출은 제한 주식 및 통제 주식에 대한 Rule 144 준수를 위한 일상적인 절차입니다. 일일 거래량과 시가총액에 비해 미미한 규모이므로 이번 사건이 평가에 미치는 영향은 거의 없겠지만, 투자자들은 내부자의 지속적인 매도 추세를 주목할 수 있습니다.

Savers Value Village, Inc. (SVV) a déposé un formulaire 144 indiquant qu'un initié prévoit de vendre jusqu'à 600 actions ordinaires par l'intermédiaire de Fidelity Brokerage Services à compter du 22 juillet 2025. Selon le prix de référence mentionné dans l'avis, la participation est évaluée à 6 306 $. Avec 157 451 564 actions en circulation, la vente proposée représente environ 0,0004 % du flottant, ce qui implique un impact de marché négligeable.

Le vendeur, identifié dans le tableau des ventes trimestrielles comme Richard Medway, a déjà cédé 36 513 actions entre mai et juillet 2025, pour un produit brut d'environ 402 000 $. Les 600 actions proviennent d'une option d'achat d'actions accordée le 12 juin 2019 et exercée en espèces à la date prévue de la vente.

Ce dépôt est une conformité de routine avec la règle 144 concernant les titres restreints/de contrôle. Étant donné la taille minime par rapport au volume quotidien et à la capitalisation boursière, cet événement est peu susceptible d'influencer la valorisation, bien que les investisseurs puissent noter la tendance continue des ventes d'initiés.

Savers Value Village, Inc. (SVV) hat ein Formular 144 eingereicht, das anzeigt, dass ein Insider beabsichtigt, bis zu 600 Stammaktien über Fidelity Brokerage Services am oder nach dem 22. Juli 2025 zu verkaufen. Basierend auf dem Referenzpreis in der Mitteilung wird der Anteil auf 6.306 $ geschätzt. Bei 157.451.564 ausstehenden Aktien entspricht der vorgeschlagene Verkauf etwa 0,0004 % des Streubesitzes, was auf einen vernachlässigbaren Markteinfluss hindeutet.

Der Verkäufer, in der Dreimonatstabelle als Richard Medway identifiziert, hat bereits zwischen Mai und Juli 2025 36.513 Aktien verkauft und dabei Bruttoerlöse von etwa 402.000 $ erzielt. Die 600 Aktien stammen aus einer Aktienoption, die am 12. Juni 2019 gewährt und am geplanten Verkaufsdatum in bar ausgeübt wurde.

Diese Meldung ist eine routinemäßige Einhaltung der Regel 144 für beschränkte/kontrollierte Wertpapiere. Angesichts der minimalen Größe im Verhältnis zum Tagesvolumen und zur Marktkapitalisierung wird das Ereignis die Bewertung wahrscheinlich nicht beeinflussen, obwohl Anleger den anhaltenden Insider-Verkaufstrend beachten könnten.

Positive
  • None.
Negative
  • Ongoing insider selling: The filer disposed of 36,513 shares in the past three months and now plans an additional 600-share sale, which some investors may view cautiously despite the small size.

Insights

600-share Form 144; negligible vs float; cumulative 36k shares sold; transaction routine; unlikely to move SVV valuation.

The proposed 600-share sale represents just 0.0004 % of Savers Value Village’s outstanding stock and follows earlier dispositions totalling 36,513 shares (~0.02 % of float). Such volumes will not affect supply-demand dynamics or dilute existing holders. The shares stem from an option exercised the same day, signalling normal liquidity management rather than strategic exit. Absent wider insider selling or adverse fundamentals, market impact is neutral.

Insider’s continued disposals small but persistent; monitor alignment, though current filing alone lacks material significance.

Rule 144 disclosures enhance transparency on insider trading. While 600 shares is trivial, four earlier sales in three months show the individual gradually trimming exposure. Percentages remain immaterial, yet persistent selling can draw scrutiny if paired with deteriorating operations. Governance risk appears low; the filer certifies no undisclosed negative information. Investors should simply watch for accelerating volumes or additional insiders following suit.

Savers Value Village, Inc. (SVV) ha presentato un Modulo 144 indicando che un insider intende vendere fino a 600 azioni ordinarie tramite Fidelity Brokerage Services a partire dal 22 luglio 2025. In base al prezzo di riferimento indicato nella comunicazione, la quota è valutata circa 6.306 $. Con 157.451.564 azioni in circolazione, la vendita proposta rappresenta circa lo 0,0004% del flottante, con un impatto di mercato trascurabile.

Il venditore, identificato nella tabella delle vendite trimestrali come Richard Medway, ha già ceduto 36.513 azioni tra maggio e luglio 2025 per un ricavo lordo di circa 402.000 $. Le 600 azioni provengono da un'opzione su azioni concessa il 12 giugno 2019 e esercitata in contanti nella data prevista per la vendita.

Questa comunicazione è una conformità di routine alla Regola 144 per titoli con restrizioni o di controllo. Considerata la dimensione minima rispetto al volume giornaliero e alla capitalizzazione di mercato, l'evento difficilmente influenzerà la valutazione, anche se gli investitori potrebbero osservare la tendenza continua delle vendite da parte degli insider.

Savers Value Village, Inc. (SVV) presentó un Formulario 144 indicando que un insider planea vender hasta 600 acciones comunes a través de Fidelity Brokerage Services a partir del 22 de julio de 2025. Según el precio de referencia en el aviso, la participación está valorada en 6,306 $. Con 157,451,564 acciones en circulación, la venta propuesta equivale aproximadamente al 0,0004% del flotante, lo que implica un impacto de mercado insignificante.

El vendedor, identificado en la tabla de ventas trimestrales como Richard Medway, ya ha vendido 36,513 acciones entre mayo y julio de 2025, obteniendo ingresos brutos de aproximadamente 402,000 $. Las 600 acciones provienen de una opción de compra otorgada el 12 de junio de 2019 y ejercida en efectivo en la fecha prevista para la venta.

Esta presentación es un cumplimiento rutinario con la Regla 144 para valores restringidos o de control. Dado el tamaño mínimo en relación con el volumen diario y la capitalización de mercado, es poco probable que el evento influya en la valoración, aunque los inversores pueden notar la tendencia continua de ventas por parte de insiders.

Savers Value Village, Inc. (SVV)는 내부자가 2025년 7월 22일 이후 Fidelity Brokerage Services를 통해 최대 600주의 보통주를 매도할 계획임을 알리는 Form 144를 제출했습니다. 공지에 명시된 기준 가격에 따르면 해당 지분 가치는 6,306달러로 평가됩니다. 총 157,451,564주가 발행된 가운데, 이번 매도는 유통 주식의 약 0.0004%에 해당하여 시장에 미치는 영향은 미미할 것으로 보입니다.

판매자는 3개월 매도 내역표에서 리처드 메드웨이(Richard Medway)로 확인되며, 2025년 5월부터 7월 사이에 이미 36,513주를 매도하여 약 40만 2천 달러의 총수익을 올렸습니다. 이번 600주는 2019년 6월 12일에 부여된 주식 옵션에서 기인하며, 계획된 매도일에 현금으로 행사되었습니다.

이번 제출은 제한 주식 및 통제 주식에 대한 Rule 144 준수를 위한 일상적인 절차입니다. 일일 거래량과 시가총액에 비해 미미한 규모이므로 이번 사건이 평가에 미치는 영향은 거의 없겠지만, 투자자들은 내부자의 지속적인 매도 추세를 주목할 수 있습니다.

Savers Value Village, Inc. (SVV) a déposé un formulaire 144 indiquant qu'un initié prévoit de vendre jusqu'à 600 actions ordinaires par l'intermédiaire de Fidelity Brokerage Services à compter du 22 juillet 2025. Selon le prix de référence mentionné dans l'avis, la participation est évaluée à 6 306 $. Avec 157 451 564 actions en circulation, la vente proposée représente environ 0,0004 % du flottant, ce qui implique un impact de marché négligeable.

Le vendeur, identifié dans le tableau des ventes trimestrielles comme Richard Medway, a déjà cédé 36 513 actions entre mai et juillet 2025, pour un produit brut d'environ 402 000 $. Les 600 actions proviennent d'une option d'achat d'actions accordée le 12 juin 2019 et exercée en espèces à la date prévue de la vente.

Ce dépôt est une conformité de routine avec la règle 144 concernant les titres restreints/de contrôle. Étant donné la taille minime par rapport au volume quotidien et à la capitalisation boursière, cet événement est peu susceptible d'influencer la valorisation, bien que les investisseurs puissent noter la tendance continue des ventes d'initiés.

Savers Value Village, Inc. (SVV) hat ein Formular 144 eingereicht, das anzeigt, dass ein Insider beabsichtigt, bis zu 600 Stammaktien über Fidelity Brokerage Services am oder nach dem 22. Juli 2025 zu verkaufen. Basierend auf dem Referenzpreis in der Mitteilung wird der Anteil auf 6.306 $ geschätzt. Bei 157.451.564 ausstehenden Aktien entspricht der vorgeschlagene Verkauf etwa 0,0004 % des Streubesitzes, was auf einen vernachlässigbaren Markteinfluss hindeutet.

Der Verkäufer, in der Dreimonatstabelle als Richard Medway identifiziert, hat bereits zwischen Mai und Juli 2025 36.513 Aktien verkauft und dabei Bruttoerlöse von etwa 402.000 $ erzielt. Die 600 Aktien stammen aus einer Aktienoption, die am 12. Juni 2019 gewährt und am geplanten Verkaufsdatum in bar ausgeübt wurde.

Diese Meldung ist eine routinemäßige Einhaltung der Regel 144 für beschränkte/kontrollierte Wertpapiere. Angesichts der minimalen Größe im Verhältnis zum Tagesvolumen und zur Marktkapitalisierung wird das Ereignis die Bewertung wahrscheinlich nicht beeinflussen, obwohl Anleger den anhaltenden Insider-Verkaufstrend beachten könnten.

false 0001712762 0001712762 2025-07-22 2025-07-22 0001712762 BIAF:CommonStockParValue0.007PerShareMember 2025-07-22 2025-07-22 0001712762 BIAF:WarrantsToPurchaseCommonStockMember 2025-07-22 2025-07-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 22, 2025

 

bioAffinity Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41463   46-5211056

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

3300 Nacogdoches Road, Suite 216

San Antonio, Texas 78217

(Address of principal executive offices, including zip code)

 

(210) 698-5334

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Title of each class   Trading Symbols   Name of each exchange on which registered

Common Stock, par value $0.007 per share

 

 

 

BIAF

 

 

The Nasdaq Stock Market LLC

(Nasdaq Capital Market)

         
Warrants to purchase Common Stock   BIAFW  

The Nasdaq Stock Market LLC

(Nasdaq Capital Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

  

 

 

Item 8.01. Other Events.

 

On July 22, 2025, bioAffinity Technologies, Inc., a Delaware corporation, (the “Company”) issued a press release announcing it has received notification of allowance from the Canadian Patent Office for a patent application related to methods of predicting the likelihood of lung cancer using flow cytometry.

 

The newly allowed Canadian patent titled “System and Method for Determining Lung Health” protects the use of defined antibodies and the porphyrin TCPP to label cell populations in sputum and the use of flow cytometry to determine the presence of lung cancer cells in the sputum.

 

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit

Number

  Description
99.1   Press Release issued by bioAffinity Technologies, Inc., dated July 22, 2025
104   Cover Page Interactive Data File (embedded within the XBRL document)

 

-2-

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 22, 2025 BIOAFFINITY TECHNOLOGIES, INC.
     
  By: /s/ Maria Zannes
  Name: Maria Zannes
  Title: President and Chief Executive Officer

 

-3-

 

FAQ

What did Savers Value Village (SVV) disclose in its latest Form 144 filing?

An insider plans to sell up to 600 SVV common shares valued at $6,306 on or after 22 Jul 2025.

How many SVV shares will be sold and what is the estimated market value?

600 shares with an aggregate market value of $6,306 according to the filing.

Who is the insider selling SVV stock and how much has he sold recently?

Richard Medway sold 36,513 shares in the past three months for approximately $402 k and now plans to sell 600 more.

What percentage of SVV’s outstanding shares does the proposed sale represent?

Roughly 0.0004 % of the 157,451,564 shares outstanding.

On which exchange and through which broker will the SVV shares be sold?

The shares are slated for sale on the NYSE via Fidelity Brokerage Services LLC.
bioAffinity Tech

NASDAQ:BIAFW

BIAFW Rankings

BIAFW Latest News

BIAFW Latest SEC Filings

BIAFW Stock Data

1.60M
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
SAN ANTONIO